BAXDELA
XEDITON PHARMACEUTICALS INC
Quick answers
Is there a shortage of BAXDELA in Canada?
No. There is no current shortage of BAXDELA 300MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
BAXDELA
XEDITON PHARMACEUTICALS INC
DIN
02554437
Strength
300MG
Dosage Form
Powder For Solution
Route
Intravenous
Active Ingredient
DELAFLOXACIN (DELAFLOXACIN MEGLUMINE)
See all DELAFLOXACIN (DELAFLOXACIN MEGLUMINE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from XEDITON PHARMACEUTICALS INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.